Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency
Status:
Not yet recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
The INERTIA trial is a multicenter double-blinded randomized trial of intravenous iron
supplementation in patients with severe aortic stenosis and iron deficiency undergoing TAVI
or SAVR. The primary endpoint is the time to HF hospital admission or cardiovascular death.
Secondary endpoints will assess quality of life indicators and functional capacity at 6
months.